tiprankstipranks
Trending News
More News >

MaxCyte Cancels AIM Market Trading for Common Stock

Story Highlights
MaxCyte Cancels AIM Market Trading for Common Stock

Don’t Miss TipRanks’ Half-Year Sale

MaxCyte ( (MXCT) ) just unveiled an announcement.

On June 25, 2025, MaxCyte, Inc. announced its decision to cancel the trading of its common stock on the AIM market of the London Stock Exchange, effective June 26, 2025. This move will not affect the company’s shares listed on the Nasdaq Global Select Market, where they will continue to trade under the ticker symbol MXCT.

The most recent analyst rating on (MXCT) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on MaxCyte stock, see the MXCT Stock Forecast page.

Spark’s Take on MXCT Stock

According to Spark, TipRanks’ AI Analyst, MXCT is a Neutral.

MaxCyte faces significant financial and technical challenges, with declining revenues and bearish technical indicators. The company’s valuation is also concerning due to negative earnings. However, strategic corporate events and some operational strengths provide a modest positive outlook.

To see Spark’s full report on MXCT stock, click here.

More about MaxCyte

Average Trading Volume: 888,614

Technical Sentiment Signal: Sell

Current Market Cap: $230.7M

For detailed information about MXCT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1